• Webinar Details

  • Home / Learn / Live CE / Live CE Event Calendar / Webinar Details


Antihyperglycemic Therapy in Type 2 Diabetes: What's Guiding Pharmacotherapy Choice?

Event Type

Live Online

Date

Tuesday, November 13, 2018

Time

8:00 PM - 9:30 PM ET

Location

PharmCon Webinar Studio (freeCE.com)

Credits

1.5 Contact Hour(s)

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$0.00

  • Overview

    Diabetes treatment options continue to expand. While this allows providers to have a larger armamentarium for treatment, questions still remain about the best option(s) to use in certain patients. Clinical inertia related to progressive diabetes management also exists for many patients and providers, making successful glycemic control even more difficult. This program will provide and overview of strategies used for recognizing and overcoming clinical inertia. It will also provide an overview of commonly used diabetes treatment options, and focus on which options are best for certain patients.

    30 days following this live webinar, participants will be invited to participate in a 30-minute follow-up home study (0.5 credit hour) that will provide the opportunity to review the main concepts from the webinar and apply what has been learned to patient cases related to diabetes treatment options.



    Rating


    Handouts

    Slide Document:   18098L01_4pp.pdf


    Slide Document:   18098L01_2pp.pdf

    Financial Support By

    Merck & Co., Inc.
  • Nurse

    Explain the effect clinical inertia can have on the management of diabetes mellitus
    Identify clinical situations appropriate for early initiation of adjunct diabetes treatment options
    Compare key medication - and disease-specific considerations for selecting adjunct diabetes treatments
    Examine benefits incurred with the early initiation of adjunct diabetes treatments
    Identify patients who could benefit from sodium glucose cotransporter 2 (SGLT2) inhibitors


    Pharmacist

    Explain the effect clinical inertia can have on the management of diabetes mellitus
    Identify clinical situations appropriate for early initiation of adjunct diabetes treatment options
    Compare key medication - and disease-specific considerations for selecting adjunct diabetes treatments
    Examine benefits incurred with the early initiation of adjunct diabetes treatments
    Identify patients who could benefit from sodium glucose cotransporter 2 (SGLT2) inhibitors


    Pharmacy Technician

    Define clinical inertia and describe its potential impact to a patient
    Identify pharmacist referral opportunities in which early initiation of diabetes education may be beneficial to a patient
    Identify and categorize key medications commonly used in the treatment of diabetes by brand name, generic name, and drug classification
    State benefits of early initiation of adjunct diabetes treatments

  • Repeat Presentation

    This presentation was last given on Monday, October 29, 2018

    Future Airings

    None

  • Activity Type

    Application

    Universal Activity Number

    Nurse 0798-0000-18-098-L01-P

    Pharmacist 0798-0000-18-098-L01-P

    Pharmacy Technician 0798-0000-18-098-L01-T

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.